Martin W.R., Eades C.E., Thompson J.A., Huppler R.E. (1976) The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther197: 517-532
2.
Monnet F.P., Debonnel G., de Montigny C. (1992) In vivo electrophysiological evidence for a selective modulation of N-methyl-D-aspartate-induced neuronal activation in rat CA3 dorsal hippocampus by sigma ligands. J Pharmacol Exp Ther261: 123
3.
Quirion R., Chicheportische R., Contreras P.C., Johnson K.M., Lodge D., Tam S.W., Woods J.H., Zukin S.R. (1987) Classification and nomenclature of phencyclidine and sigma receptor sites. Trends Neurosci10: 444-446
4.
Quirion R., Bowen W.D., Itzhak Y., Junien J.L.Musacchio J.M., Rothman R.B., Su T.P., Tam S.W., Taylor D.P. (1992) A proposal for the classification of sigma binding sites. Trends Pharmacol Sci13: 85-86
5.
Su T.P. (1982) Evidence for sigma opioid receptor: binding of [3H]SKF-10047 to etorphine-inaccessible sites in guinea-pig brain. J Pharmacol Exp Ther223: 284-290
6.
Vapuel D.B. (1983) Naltrexone fails to antagonize the effects of PCP and SKF 10047 in the dog. Eur J Pharmacol92: 269-274
7.
Walker J.M., Matsumoto R.R., Bowen W.D., Gans D.L., Jones K.D., Walker F.O. (1988) Evidence for a role of halperidol-sensitive σ-"opiate" receptors in the motor effects of antipsychotic drugs. Neurology38: 961-965
8.
Walker J.M., Bowen W.D., Patrick S.L., Williams W.E., Mascarella S.W., Bai X., Carroll F.I. (1993) A comparison of (-)-deoxybenzomorphans devoid of opiate activity with their dextrorotatory phenolic counterparts suggests role of σ2 receptors in motor function. Eur J Pharmacol231: 61-68
9.
Weber E., Sonders M., Quarum M., McLean S., Pou S., Keana J F W (1986) 1,3-di(2- [5-3H] tolyl)guanidine: a selective ligand that labels σ-type receptors for psychotomimetic opiates and antipsychotic drugs. Proc Natl Acad Sci USA83: 8784-8788
